Safety of tildrakizumab for moderate‐to‐severe plaque psoriasis: pooled analysis of three randomized controlled trials
暂无分享，去创建一个
A. Kimball | S. Green | M. Gooderham | K. Papp | K. Reich | A. Blauvelt | R. Sinclair | S. Tyring | D. Thaçi | C. La Rosa | Q. Li | N. Cichanowitz | C. L. Rosa | Kristian Reich | S. Tyring | A. Blauvelt | K. Papp | Diamant Thaçi | M. Gooderham | Alexa B. Kimball | Rodney Sinclair | Stuart A. Green